Speak directly to the analyst to clarify any post sales queries you may have.
Healthcare organizations are rethinking fraud detection as digital transformation, regulatory scrutiny, and advanced data protection become central to daily operations. Senior leaders are prioritizing integrated strategies that address emerging digital threats and compliance challenges while supporting innovation in patient care delivery and system management.
Market Snapshot: Healthcare Fraud Detection Market Size and Growth Trends
The healthcare fraud detection market is on a steep growth trajectory, advancing from USD 2.22 billion in 2024 to a projected USD 10.47 billion by 2032. The sector is witnessing a compound annual growth rate of 21.34%. This expansion is closely linked to the increased integration of digital workflows—such as claims management, billing, and electronic prescriptions—across hospitals, insurers, and pharmacy networks. Organizations are making significant investments in machine learning and real-time analytics for anomaly detection. Cloud technology not only increases scalability but also brings agility to respond quickly to emerging risks. Regulatory pressure and the need for operational assurance are accelerating the shift toward more advanced fraud detection models industrywide.
Scope & Segmentation: Comprehensive Analysis Across Technology, Deployment, and End Users
This report offers in-depth segmentation and actionable insights to empower executive decision-making:
- Component: Service-based solutions feature consulting, technical support, maintenance, and system integration. Technology offerings include analytics, detection software, behavioral recognition, real-time monitoring, and rule-based filtering to provide ongoing oversight across diverse environments.
- Deployment: Both cloud-based and on-premise models allow organizations to tailor fraud detection to their data protection, privacy, and regulatory requirements, ensuring that solutions meet local and global standards.
- Application: Capabilities focus on billing abuse management, claims fraud detection, enrollment oversight, and prescription monitoring. These areas are critical focal points for reducing financial exposure and ensuring compliance.
- End User: Solutions support private hospitals, public facilities, government and private insurers, and both online and brick-and-mortar pharmacies, enabling each segment to address distinct fraud challenges efficiently.
- Fraud Type: Addresses a wide spectrum, including billing fraud, identity fraud, insurance fraud, and pharmaceutical fraud. This approach supports layered defense to keep pace with increasingly sophisticated threats.
- Geographical Coverage: Regional analysis spans the Americas (highlighting the U.S. and Latin America), Europe (Western and Eastern), the Middle East, Africa, and Asia-Pacific. Each region features unique regulatory climates and adoption drivers, which influence implementation strategies and technology uptake.
- Leading Providers: Key participants include SAS Institute Inc., IBM Corporation, Optum, Inc., Cotiviti, Inc., Fair Isaac Corporation, Pegasystems Inc., Verisk Analytics, Inc., DXC Technology Company, NICE Ltd., and LexisNexis Risk Solutions Inc. Their innovations shape the global healthcare fraud management landscape.
Key Takeaways: Strategic Insights for Decision Makers
- Predictive modeling and behavioral analytics are transforming risk identification by enabling earlier detection and response to complex fraud patterns.
- Collaboration across IT, compliance, and business units is streamlining the integration of anti-fraud controls, maintaining alignment with evolving healthcare regulations.
- Rising adoption of telehealth and electronic patient records calls for real-time data integration and surveillance, equipping organizations to act swiftly against novel threats.
- Cloud-based detection solutions enhance scalability and flexibility, ensuring organizations can quickly adjust their fraud strategies as regulatory expectations shift over time.
- Tightening data privacy mandates, particularly in regions like Europe, require providers to reinforce security while leveraging advanced analytics to strengthen fraud mitigation efforts.
- Industry consolidation is facilitating broader solution sets, providing enterprises with integrated risk management platforms and comprehensive anti-fraud capabilities.
Tariff Impact: U.S. Market Adjustments
Forthcoming U.S. import tariffs are poised to affect hardware costs for essential data storage and surveillance components within healthcare fraud detection platforms. These changes could also influence software licensing arrangements and impact the overall supply chain. To remain competitive and compliant, senior executives should assess sourcing alternatives, consider adopting cloud-based solutions when practical, and review procurement strategies to balance cost management with regulatory requirements as the landscape evolves.
Methodology & Data Sources
The insights in this healthcare fraud detection report are derived from comprehensive secondary research, interviews with C-suite healthcare executives, and advanced market modeling. Validation processes, including triangulation and sensitivity analysis, ensure projections are robust and relevant for commercial strategy.
Why This Report Matters
- Equips senior teams with a clear framework to navigate the regulatory, technological, and operational aspects of healthcare fraud detection.
- Guides technology choices and vendor negotiations by spotlighting critical priorities and ecosystem partners essential to effective risk mitigation.
- Enhances organizational agility and policy adaptability, preparing stakeholders to respond confidently to evolving threats and compliance shifts in global markets.
Conclusion
By focusing on integrated and adaptive fraud detection strategies, healthcare enterprises will be better positioned to meet ongoing risk and compliance demands as technology and regulations develop.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples
LOADING...
Companies Mentioned
The key companies profiled in this Healthcare Fraud Detection market report include:- SAS Institute Inc.
- IBM Corporation
- Optum, Inc.
- Cotiviti, Inc.
- Fair Isaac Corporation
- Pegasystems Inc.
- Verisk Analytics, Inc.
- DXC Technology Company
- NICE Ltd.
- LexisNexis Risk Solutions Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 198 |
Published | October 2025 |
Forecast Period | 2025 - 2032 |
Estimated Market Value ( USD | $ 2.7 Billion |
Forecasted Market Value ( USD | $ 10.47 Billion |
Compound Annual Growth Rate | 21.3% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |